Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Pan-Lin Asset Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 46
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 35
Rounds per year 3.54
Lead investments 15
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.24
Exits 2
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Manufacturing
  • Electronics
Summary

The leading representative office of defined Corporate Investor is situated in the Shanghai. The venture was found in Asia in China.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Pan-Lin Asset Management, startups are often financed by Zhizhuo Capital, ZhenFund, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Matrix Partners China, ZhenFund, South China Venture Capital. In the next rounds fund is usually obtained by Zhizhuo Capital, ZhenFund, Sigma Square Capital.

We can highlight the next thriving fund investment areas, such as Health Care, Enterprise. For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight YCloset, Apollomics, XGIMI. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

The important activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
#Angels California, San Francisco, United States
Angel List -
Cachet Asset Management China, Hong Kong, Hong Kong Island
Caltrop California, Riverside, United States
Cantora New York, New York, United States
Castle Connolly Medical Ltd. New York, New York, United States
ClearVue Partners China, Shanghai, Shanghai
Cockpit Innovation Israel, Tel Aviv, Tel Aviv District
CSAA Insurance Group California, United States, Walnut Creek
Fortune Link China, Shanghai
Glikvest -
Global Assets Investment England, London, United Kingdom
Grapeseed.Bio La Fayette, New York, United States
iEurope Capital New York, New York, United States
Lanza Tech Ventures California, Palo Alto, United States
Shenxuan Investment Management China, Hangzhou, Zhejiang
SkyKnight Capital California, San Francisco, United States
Stic Investment Seoul, Seoul-t'ukpyolsi, South Korea
TechFund France, Ile-de-France, Paris
Yangon Capital Partners (YCP) -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Fibresound Technology

Advanced Materials
Electronics
Semiconductor
22 Nov 2023 Chengdu, Sichuan, China

Shitong Microelectronics

3D Technology
Electronics
Sensor
$1K13 Nov 2023 Shanghai, Shanghai, China

O-Cubes

Hardware
Product Research
Wireless
31 Oct 2023 Shanghai, Shanghai, China

Levinthal

Artificial Intelligence
Biotechnology
Product Design
$1K27 Jul 2023 Hangzhou, Zhejiang, China

Easy Logic

Electronic Design Automation (EDA)
Electronics
Manufacturing
22 May 2023 Shenzhen, Guangdong, China

Tingke Biotechnology

Biopharma
Biotechnology
Manufacturing
03 Mar 2023 Hangzhou, Zhejiang, China

Zhishan Weixin Biotechnology

Biotechnology
Health Care
Product Research
$309K01 Feb 2023 Chengdu, Sichuan, China

Ruiyun Cold Chain

Logistics
Service Industry
$30M22 Nov 2022 China, Beijing, China

NuProbe

Biotechnology
Health Care
Health Diagnostics
$50M02 Jun 2022 Boston, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pan-Lin Asset Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 46
Average round size 20M
Rounds per year 3.54
Peak activity year 2021
Lead investments 15
Follow on index 0.24
Exits 2
Group Appearance index 0.78

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Fibresound Technology

Advanced Materials
Electronics
Semiconductor
22 Nov 2023 Chengdu, Sichuan, China

Shitong Microelectronics

3D Technology
Electronics
Sensor
$1K13 Nov 2023 Shanghai, Shanghai, China

O-Cubes

Hardware
Product Research
Wireless
31 Oct 2023 Shanghai, Shanghai, China

Levinthal

Artificial Intelligence
Biotechnology
Product Design
$1K27 Jul 2023 Hangzhou, Zhejiang, China

Easy Logic

Electronic Design Automation (EDA)
Electronics
Manufacturing
22 May 2023 Shenzhen, Guangdong, China

Tingke Biotechnology

Biopharma
Biotechnology
Manufacturing
03 Mar 2023 Hangzhou, Zhejiang, China

Zhishan Weixin Biotechnology

Biotechnology
Health Care
Product Research
$309K01 Feb 2023 Chengdu, Sichuan, China

Ruiyun Cold Chain

Logistics
Service Industry
$30M22 Nov 2022 China, Beijing, China

NuProbe

Biotechnology
Health Care
Health Diagnostics
$50M02 Jun 2022 Boston, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: